Literature DB >> 6848553

Hemodynamic sequelae of regression of experimental atherosclerosis.

M L Armstrong, D D Heistad, M L Marcus, D J Piegors, F M Abboud.   

Abstract

Regression of experimental atherosclerosis is characterized by decreased intimal thickness and luminal enlargement, but intimal fibrosis becomes more dense. We tested the hypothesis that fibrosis of arteries during regression might limit vasodilator capacity and restrict hemodynamic improvement despite luminal improvement. We studied limb, coronary, and cerebral hemodynamics in 11 normal cynomolgus monkeys, 10 monkeys given an atherogenic diet for 20 mo and 8 monkeys given a regression diet for an additional 18 mo. The atherogenic diet induced lesions of moderate severity (50-60% stenosis); owing to characteristic vessel growth during the atherogenic period, luminal size did not decrease correspondingly. Regression monkeys showed typical changes of regression with luminal enlargement but increased fibrosis. The iliac artery was perfused at constant blood flow and maximal vasodilatation was produced with papaverine. Blood flow was measured with microspheres during maximal vasodilatation in the coronary bed (adenosine) and cerebral bed (hypercapnia). In normal monkeys, minimal vascular resistances were 1.95 +/- 0.19 mm Hg/ml/min X 100 g (mean +/- SE) (limb), 0.13 +/- 0.01 (coronary), and 0.44 +/- 0.02 (cerebral). In atherosclerotic monkeys minimal resistance increased (P less than 0.05) 108, 62, and 166% in the limb, coronary, and cerebral beds, respectively. In regression monkeys, minimal resistance increased from values found in atherosclerotic animals in the limb (+22%), decreased inconsistently in the coronary bed (-19%), and decreased significantly in the cerebral bed (-44%, P less than 0.05). Thus morphologic regression was accompanied by significant hemodynamic improvement during maximal dilatation only in cerebral vessels. We conclude that increases in luminal size during regression of atherosclerotic lesions may not be associated with increases in vasodilator capacity, as intimal fibrosis may limit physiologically important hemodynamic improvement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848553      PMCID: PMC436842          DOI: 10.1172/jci110738

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.

Authors:  L L ABEL; B B LEVY; B B BRODIE; F E KENDALL
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

2.  Total and regional cerebral blood flow measurement with 7-10-, 15-, 25-, and 50-mum microspheres.

Authors:  M L Marcus; D D Heistad; J C Ehrhardt; F M Abboud
Journal:  J Appl Physiol       Date:  1976-04       Impact factor: 3.531

3.  Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets.

Authors:  M L Armstrong; M B Megan
Journal:  Circ Res       Date:  1972-06       Impact factor: 17.367

4.  Morphology and distribution of diet-induced atherosclerosis in rhesus monkeys.

Authors:  M L Armstrong; E D Warner
Journal:  Arch Pathol       Date:  1971-12

5.  Regression of coronary atheromatosis in rhesus monkeys.

Authors:  M L Armstrong; E D Warner; W E Connor
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

6.  Comparative changes in segmental vascular resistance in response to nerve stimulation and to norepinephrine.

Authors:  F M Abboud; J W Eckstein
Journal:  Circ Res       Date:  1966-03       Impact factor: 17.367

7.  Arterial fibrous proteins in cynomolgus monkeys after atherogenic and regression diets.

Authors:  M L Armstrong; M B Megan
Journal:  Circ Res       Date:  1975-02       Impact factor: 17.367

8.  A model for therapeutic interventins on established coronary atherosclerosis in a nonhuman primate.

Authors:  M R Malinow; O McLaughlin; L Papworth; H K Naito; L Lewis; W P McNulty
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

9.  Effects of hyperlipoproteinemias and their treatment on the peripheral circulation.

Authors:  R Zelis; D T Mason; E Braunwald; R I Levy
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

10.  Regression of early cholesterol-induced aortic lesions in rhesus monkeys.

Authors:  C F Tucker; C Catsulis; J P Strong; D A Eggen
Journal:  Am J Pathol       Date:  1971-12       Impact factor: 4.307

View more
  7 in total

1.  Assessment of effect of angiotensin II receptor antagonist losartan on aortic distensibility in patients with essential hypertension by echocardiography.

Authors:  Haoyi Yang; Youbin Deng; Chunlei Li; Xiaojun Bi; Min Pan; Qing Chang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

2.  Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulinlike growth factor I.

Authors:  D R Clemmons; R G Elgin; V K Han; S J Casella; A J D'Ercole; J J Van Wyk
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 3.  The effect of exercise on lipid metabolism in men and women.

Authors:  L Goldberg; D L Elliot
Journal:  Sports Med       Date:  1987 Sep-Oct       Impact factor: 11.136

4.  Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis.

Authors:  Bojana Stanic; Deepesh Pandey; David J Fulton; Francis J Miller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-09       Impact factor: 8.311

5.  Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis.

Authors:  D G Harrison; M L Armstrong; P C Freiman; D D Heistad
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 6.  Endothelial function in the time of the giants.

Authors:  Donald D Heistad
Journal:  J Cardiovasc Pharmacol       Date:  2008-11       Impact factor: 3.105

Review 7.  What causes spasm of atherosclerotic arteries? Is regression of plaques beneficial?

Authors:  D D Heistad; M L Armstrong; J A Lopez
Journal:  Trans Am Clin Climatol Assoc       Date:  1990
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.